Clovis Oncology (CLVS) Defended at SunTrust
Tweet
Share
E-mail
Get Alerts CLVS Hot Sheet
Price: $0.08 --0%
Rating Summary:
7 Buy, 7 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Rating Summary:
7 Buy, 7 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE
In addition to Piper (noted earlier), SunTrust is out defending Clovis Oncology (NASDAQ: CLVS) saying there nothing significantly new in the data. Shares of CLVS are down 13.7% after trading down nearly 30% earlier.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Natera (NTRA) PT Raised to $270 at BTIG
- Goldman Sachs Starts Lovisa Holdings Ltd (LOV:AU) at Neutral
- American Airlines (AAL) PT Raised to $21 at UBS Ahead of Q2 Earnings
Create E-mail Alert Related Categories
Analyst Comments, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
